deltatrials
Recruiting OBSERVATIONAL NCT06804525

LHC-CIDI-5 in Hong Kong

Use of Life History Calendars to Enhance Measurement of Lifetime Experience With Mental Disorders in Hong Kong.

Sponsor: The University of Hong Kong

Conditions Alcohol Use Disorder (AUD) Bipolar I Disorder Bipolar II Disorder Bipolar Sub Disorder Generalized Anxiety Disorder (GAD) Hypomanic Intermittent Explosive Disorder (IED) Major Depressive Disorder (MDD) Major Depressive Episode (MDE) Manic Episode Nonsuicidal Self-Injury Obsessive-Compulsive Disorder (OCD) PCL-5 PTSD PCL-SC PTSD Panic Attack Panic Disorder Persistent Depressive Disorder (PDD) Posttraumatic Stress Disorder (PTSD) Substance Use Disorder (SUD) Suicidal Attempt Suicidal Gesture Suicidal Ideation Suicidal Plan
Interventions CIDI-5 LHC-CIDI-5
Updated 4 times since 2025 Last updated: Mar 9, 2026 Started: Jan 18, 2025 Primary completion: Sep 30, 2026 Completion: Apr 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Alcohol Use Disorder (AUD) and Bipolar I Disorder and is currently actively recruiting participants. The University of Hong Kong leads this study, which shows 4 recorded versions since 2025 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

~Mar 2025 – ~Jun 2025 · 3 months · monthly snapshotRecruiting~Jun 2025 – ~Dec 2025 · 6 months · monthly snapshotRecruiting~Dec 2025 – ~Mar 2026 · 3 months · monthly snapshotRecruiting~Mar 2026 – present · 4 months · monthly snapshotRecruiting

Change History

4 versions recorded

  1. Mar 2026 — Present [monthly]

    Recruiting

  2. Dec 2025 — Mar 2026 [monthly]

    Recruiting

  3. Jun 2025 — Dec 2025 [monthly]

    Recruiting

  4. Mar 2025 — Jun 2025 [monthly]

    Recruiting

    First recorded

Jan 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • The University of Hong Kong
Data source: The University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations